Accelerating Cancer Drug Development - From target to patients

Focusing upon the strengths in the discovery, development and manufacture of cancer medicines in the North of England through to commercialisation (patients), this event will highlight industry, academic and clinical strengths whilst showcasing key activities, infrastructure and the joined up translational environment which exists in the North.

We are delighted to have Susan Galbraith, Vice President of Oncology at AstraZeneca and Rob Bristow, Director of MCRC and Chief Academic Officer at The Christie NHS Foundation Trust as Keynote Speakers.

Delegate Fees
Premium Member: £125.00 + VAT
Member: £155.00 + VAT
Non-Member: £250.00 + VAT

If you are interested in exhibiting at the event, please contact Helen Williams at [email protected] for further information.

Delegate Fees
Premium Member: £125.00 + VAT
Member: £155.00 + VAT
Non-Member: £250.00 + VAT

If you are interested in exhibiting at the event, please contact Helen Williams at [email protected] for further information.